Heparin Problems Renew Questions Of Liability

By Jacqueline Bell (February 15, 2008, 12:00 AM EST) -- As pharmaceutical company Baxter International Inc. investigates the four deaths and scores of allergic reactions linked to its blood thinner heparin, news that the drug's active ingredient was likely made in a Chinese factory has raised now-familiar concerns about the safety of Chinese exports, and complex questions of who's on the hook when pharmaceuticals are found to be toxic....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!